Inventor · disambiguated record
Beili Zhang
Also filed as: ZHANG BEILI
32 granted patents·16 pending applications·1,295 citations·filing 2008–2023
98Inventor score
Top patents by PatentIndex Score
48 records- 0199US9840499B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acidVERTEX PHARMA·Filed 2016·Granted Dec 12, 2017·41 cites·1 claims
- 0299US9434717B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acidVERTEX PHARMA·Filed 2015·Granted Sep 6, 2016·53 cites·5 claims
- 0399US8846718B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxo1-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acidVERTEX PHARMA·Filed 2013·Granted Sep 30, 2014·77 cites·23 claims
- 0498US10787472B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2019·Granted Sep 29, 2020·12 cites·40 claims
- 0598US10081621B2Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2015·Granted Sep 25, 2018·29 cites·22 claims
- 0698US9150552B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acidVERTEX PHARMA·Filed 2014·Granted Oct 6, 2015·58 cites·22 claims
- 0798US9051303B2Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-YL)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan-2-YL)-1H-indol-5-YL)-cyclopropanecarboxamideVERTEX PHARMA·Filed 2014·Granted Jun 9, 2015·59 cites·25 claims
- 0898US8969574B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHARMA·Filed 2014·Granted Mar 3, 2015·61 cites·7 claims
- 0998US8802868B2Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-CyclopropanecarboxamideVERTEX PHARMA·Filed 2012·Granted Aug 12, 2014·68 cites·40 claims
- 1098US8742122B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHARMA·Filed 2013·Granted Jun 3, 2014·67 cites·7 claims
- 1198US8653103B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidKESHAVARZ-SHOKRI ALI·Filed 2012·Granted Feb 18, 2014·79 cites·1 claims
- 1298US8507687B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidKESHAVARZ-SHOKRI ALI·Filed 2011·Granted Aug 13, 2013·83 cites·5 claims
- 1398US8507534B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidKESHAVARZ-SHOKRI ALI·Filed 2008·Granted Aug 13, 2013·101 cites·23 claims
- 1497US11578062B2Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2020·Granted Feb 14, 2023·4 cites·19 claims
- 1597US10906891B2Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2018·Granted Feb 2, 2021·13 cites·14 claims
- 1697US10597384B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acidVERTEX PHARMA·Filed 2017·Granted Mar 24, 2020·17 cites·4 claims
- 1797US9828397B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2016·Granted Nov 28, 2017·23 cites·109 claims
- 1897US8741922B2Solid forms of N-(4-(7-azabicyclo[2.2,1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamideVERTEX PHARMA·Filed 2013·Granted Jun 3, 2014·68 cites·9 claims
- 1997US8436014B2Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamideZHANG BEILI·Filed 2009·Granted May 7, 2013·87 cites·13 claims
- 2096US11873300B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Jan 16, 2024·6 cites·25 claims
- 2196US10570115B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Feb 25, 2020·23 cites·18 claims
- 2296US10253054B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2017·Granted Apr 9, 2019·17 cites·38 claims
- 2396US9464102B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2015·Granted Oct 11, 2016·23 cites·21 claims
- 2496US9314455B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHAMRACEUTICALS INC·Filed 2015·Granted Apr 19, 2016·51 cites·37 claims
- 2596US9163042B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2014·Granted Oct 20, 2015·46 cites·20 claims
- 2696US8389727B2Solid forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-CarboxamideZHANG BEILI·Filed 2010·Granted Mar 5, 2013·85 cites·53 claims
- 2794US11773119B2Prodrugs of pyridone amides useful as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Oct 3, 2023·2 cites·20 claims
- 2894US11155533B2Crystalline forms and compositions of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Oct 26, 2021·10 cites·13 claims
- 2993US10654829B2Crystalline forms and compositions of CFTR modulatorsVERTEX PHARMA·Filed 2018·Granted May 19, 2020·21 cites·23 claims
- 3092US11186566B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Nov 30, 2021·10 cites·10 claims
- 3185US12319693B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 3283US12065432B2Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acidVERTEX PHARMA·Filed 2020·Granted Aug 20, 2024·1 cites·18 claims
- 3382US2023331712A1Solid forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamideVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 3471US2022306606A1Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3560US2013085158A1Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acidVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3658US2025243176A1(s)-1-(1-acryloylpiperidin-3-yl)-2-fluoro-5,6,7,8,9,10-hexahydrocyclo hepta[b]indole-4-carboxamide, and related crystalline forms, compositions, and methods thereofGB005 INC·Filed 2022·Application pending·0 cites
- 3758US2024228462A1Crystalline forms of n-{3-[(1s)-1-{[6-(3,4-dimethoxyphenyl)pyrazin-2- yl]amino}ethyl]phenyl}-5-methylpyridine-3-carboxamide and related products and methodsGB002 INC·Filed 2022·Application pending·0 cites
- 3858US2013158071A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 3958US2019038615A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 4057US2013338188A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 4157US2013131107A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 4256US2018153874A1Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2017·Application pending·0 cites
- 4352US2016022665A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 4451US2016022664A2Pharmaceutical Compositions and Administrations ThereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 4551US2014113933A9Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamideVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 4649US2016067239A9Pharmaceutical compositions and administrations thereofVERTEX PHARMA·Filed 2015·Application pending·0 cites
- 4742US2021009560A1Crystalline forms of modulators of cftrVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 4839US2011251253A1Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamideVERTEX PHARMA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Beili Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →